Related by context. All words. (Click for frequent words.) 74 #:# mediaQueryString http:/static.washingtonposFilmworkers 73 durations 65 #:# mediaQueryString 63 #:# mediaQueryString http:/static.washingtonpostZanatta 59 Duration 53 lasts 52 Auditioning actors 51 length 50 brightness backlight 48 CFSG1 receives fixed 47 Length 47 untreated psychosis 47 shortened 45 timepoints 45 cyclicity 45 postintervention 45 CFSG receives 44 PMVS 44 dosing interval 44 extended 44 periods 44 secondary efficacy endpoint 44 Our PMVS 44 shorter 43 dose titration 43 progression TTP 43 Kaplan Meier estimate 43 prolonged 43 interquartile range 42 VO2 peak 42 shelflife 42 during 42 hypopnea 42 intervals 42 oftime 42 lifespan 42 shortening 42 lasted 42 androgen suppression 42 rates EURIBORSWD = 42 apnea hypopnea 42 clopidogrel therapy 41 shorter durations 41 shorten 41 subcutaneous infusion 41 Durations 41 maturity WAM 41 lengthen 41 prolongation 41 preceding 41 mobilization demobilization 41 Tasigna prolongs 40 Secondary endpoints include 40 timeframe 40 Paleocene Eocene thermal 40 titration phase 40 detraining 40 #day [001] 40 threemonth 40 short 40 daytime somnolence 40 period 40 timespan 40 Eric Martello 40 apneic 40 esophageal acid 39 periodicity 39 scope 39 severity 39 pretreatment baseline 39 QRS duration 39 cardiac morbidity 39 wrist actigraphy 39 dayrate amounts 39 decrements 39 PLMS 39 aplindore 39 #hours [002] 39 convexity 39 corrosion perforation 39 frequency 39 sub maximal 39 varying durations 39 expiratory flow 39 calorie restriction CR 38 posttreatment 38 telephoto focal 38 AMOR IPAT 38 circadian misalignment 38 continuous intravenous infusion 38 chronicity 38 disease progression TTP 38 inhaled tobramycin 38 6MW distance 38 polysomnography PSG 38 submaximal 38 urate lowering therapy 38 producing wellbores 38 endometrial thickness 38 telomerase activity 38 shortens 38 lengthens 38 refuel Lochbaum 38 crossclamp 38 acting inhaled anticholinergic 38 fully asymptotic 38 preintervention 38 Gentle Path compound 38 WEGENER focuses 38 citalopram hydrobromide 38 follicular phase 38 CPAP adherence 38 asymptomatic AF 38 dose escalation phase 38 msec 38 continuously abstinent 38 Company website www.lifepointhospitals.com 38 spokesman Francois Manardo 38 ropinirole 38 Conde Agudelo 37 Prolongation 37 Apgar scores 37 term 37 optimal dosing 37 Widths vary 37 antiretroviral naive 37 PASI score 37 timepoint 37 telaprevir dosing 37 MMSE score 37 Russian Valeri Polyakov 37 QRS interval 37 daytime alertness 37 durational 37 oral prednisolone 37 postinjury 37 QT intervals 37 claudication 37 longer 37 inspiratory 37 Triple witching 37 acting bronchodilators 37 oscillation frequency 37 antidepressant pharmacotherapy 37 plasma concentration Cmax 37 indeterminate 37 subsequent 37 XR NTX 37 hypoglycemia unawareness 37 Pattern Trapper ADVANCED Short 37 paranasal sinuses 37 lenght 37 infrequency 37 FFNS 37 Somnolence 37 loan amortizes 37 Erectile Function IIEF 37 PCR OI 37 brachial artery flow 37 ragweed allergic 37 intermittent dosing 37 prolonged immobilization 37 postoperative mortality 37 nevirapine regimen 37 min #mn 37 specified 37 prolong 37 Likert pain 37 genotypic resistance 37 #mg/m# [002] 37 Secondary endpoints 37 varies depending 36 moderately emetogenic 36 cecal intubation 36 indiplon capsules 36 symptom exacerbation 36 tumor histology 36 QTcF 36 acromegalic patients 36 activated partial thromboplastin 36 leaf wetness 36 non progressors 36 Excused absences 36 sixmonth 36 desaturation 36 TPO mimetic 36 circadian cycle 36 postprandial glucose 36 gastric pH 36 mm ³ 36 serum HCV RNA 36 walk distance 6MWD 36 randomized #:#:# 36 serum aminotransferase levels 36 LTROs 36 boredom punctuated 36 serum cotinine levels 36 PLMs 36 minimum 36 APTIVUS r 36 radiographic progression 36 nighttime awakenings 36 LTRO 36 resolves spontaneously 36 urinary albumin excretion 36 lengthened 36 alicaforsen enema 36 INVEGA ® 36 subcutaneous PRO 36 timeframes 36 hospitalization Finelli 36 QTc 36 dosage regimens 36 7pm 7am 36 GnRH agonist 36 maximum 36 postoperative complications 36 oral prednisone 36 continuous 36 postoperative chemotherapy 36 divalproex sodium 36 tolterodine 36 anagen 36 oxygen desaturation 36 extubation 36 concentration Cmax 36 μsec 36 bareboat employment 36 fraction LVEF 36 repeat paracentesis 36 bearspread 36 cerebral ischemic 36 CI -#.# 36 oral corticosteroids 36 periodically reassessed 36 pulse widths 36 #μs [002] 36 lengthening 36 gastric acid secretion 36 Tmax 36 remainder 36 Index CDAI 36 varying lengths 36 Dose escalation 36 attain statistical significance 35 symptomatic intracranial hemorrhage 35 Crohn Disease Activity 35 diurnal cycle 35 gamma ray bursts GRBs 35 Secondary efficacy endpoints 35 SpO 2 35 oocytes retrieved 35 BTCP 35 hour bronchodilation 35 EDSS scores 35 + 2EV 35 linear regression models 35 eszopiclone 35 severe neutropenia 35 mg/m2/day 35 onset 35 nsec 35 presentence credits 35 Atlantic Multidecadal Oscillation AMO 35 dipyridamole 35 prolongs 35 Kaplan Meier estimates 35 plasma cortisol 35 obstructive apnea 35 label titration 35 Index CDAI score 35 Kaplan Meier 35 Fees vary 35 concurrent 35 Score DAS# 35 nasal airflow 35 depending 35 collected saliva samples 35 postdischarge 35 inpatient hospitalizations 35 span 35 intravenous IV infusion 35 IQR 35 NIHSS score 35 randomized multicenter Phase III 35 symptom severity 35 elapses 35 Palaeocene Eocene thermal 35 GI motility 35 lasting 35 postprocedure 35 QTc interval 35 timings 35 CD# upregulation 35 analgesic efficacy 35 APRISO 35 tapentadol ER 35 MSLT 35 Viral load 35 CSBM 35 seropositivity 35 SIMPADICO 35 tumor progression TTP 35 incubation period 35 IELT 35 spirometric 35 nausea somnolence 35 prolongations 35 hypofractionated radiation 35 long 35 measure ye mete 35 HAQ DI 35 rhythmicity 35 cycle ergometer 35 3hours 35 detectable HCV RNA 35 HER2 expression 35 shiftwork 35 overnight polysomnography 35 rFSH 35 cm sec 35 spontaneous bowel movements 35 pegylated IFN 35 inhaled iloprost 35 bipolar mania trials 35 postprandial blood glucose 35 wakings 35 dual antiplatelet therapy 35 Main Outcome Measure 35 corrected QT interval 35 peak VO2 35 CorVue ™ 35 virologic breakthrough 35 benign gastric ulcers 35 shortest 35 wavelength infrared 35 ischemic cerebrovascular 35 Shutter speeds 35 mmHg systolic 35 dyspnea shortness 35 recurrent VTE 35 respirable droplets delivered 35 apneic episodes 35 correlated inversely 35 prospectively stratified 35 desvenlafaxine succinate 35 urinary sodium excretion 35 divalproex 35 ankle dorsiflexion 35 Takafumi Yamawaki senior 35 EEG readings 35 antiviral efficacy 35 hyperalgesia 35 androgen blockade 35 mg kg dose 35 QRS width 35 prolonging 35 IU ml 35 Tamilee Webb 35 EPA LUCAS DOLEGA 35 thorough QT 35 anticoagulant medications 35 corticosteroid dose 35 actigraphy 35 Value LTV 35 Lupuzor ™ 35 Rice Topped 35 ventricular repolarization 35 incontinence episodes 35 release fampridine tablets 34 limiting generalizability 34 preoperative radiotherapy 34 maximal 34 adenoma recurrence 34 pharmacodynamic effects 34 Secondary endpoints included 34 symptom onset 34 dosed intravenously 34 cosmic ray intensity 34 CR nPR 34 V# max 34 dose corticosteroids 34 PTNS therapy 34 Approximate 34 CMV reactivation 34 Accommodative policies 34 Subjects 34 intravaginal ejaculatory latency 34 plantar pressures 34 pharmacokinetic parameters 34 maximal oxygen 34 cessations 34 Score IPSS 34 1hour 34 HAM D# 34 photoperiod 34 6MWT 34 lacosamide 34 Brief Pain 34 term prognosis Eisold 34 varies 34 peri menopause 34 participants 34 dosage regimen 34 mild renal impairment 34 pulse width 34 stipulated 34 HIV seroconversion 34 Chronic pancreatitis 34 Bichenov 34 graded vesting 34 ‰ ¥ 34 HbA1C levels 34 pulse amplitude 34 MVax 34 shortterm 34 mg Pycnogenol 34 CIMZIA TM 34 ADCS ADL 34 dose cohort 34 mg/m2 dose 34 oral methylnaltrexone 34 www.janus.com ir 34 postrelease supervision 34 droplet size 34 Zerenex Phase 34 longest 34 nasal symptoms 34 cosmic ray flux 34 worktime 34 bronchodilation 34 TDF FTC 34 FASLODEX #mg 34 inhaled budesonide 34 QT syndrome 34 rFIXFc 34 UNOMIG mandate 34 Raptiva r 34 Visual Analogue Scale VAS 34 solifenacin 34 Measurement Period 34 rapid virological response 34 UI DIARY 34 #.#x MADS [002] 34 annualized relapse 34 intradermal injections 34 DAF #a 34 post prandial glucose 34 Endothelial function 34 Chronic bronchitis 34 urate lowering 34 adversely affect Curis 34 related hematological toxicity 34 plasma HCV RNA 34 symptomatic atrial fibrillation 34 value ratios LTVs 34 subcutaneous methylnaltrexone 34 serum concentrations 34 diurnal variation 34 photokeratitis 34 platinum bob yodeled 34 approximated 34 â ‰ ¥ 34 esophageal pH 34 Bykere 34 Shortening 34 baseline CD4 34 laxation 34 dosing intervals 34 rapped convincingly 34 4km h 34 tolerated dose MTD 34 Inventory BPI 34 USL# 34 Rapid Virological Response 34 dosing cohort 34 nautical mile radius 34 serum calcium levels 34 Skin sterol 34 QTc intervals 34 Extended 34 Score DAS 34 hypobaric 34 dosing frequency 34 Febrile neutropenia 34 low dose cytarabine 34 acting insulins 34 mg orally 34 gestations 34 recombinant vector 34 postoperative 34 calcium antagonist 34 Lengthening 34 Duration Gap 34 nasal symptom 34 Cmax 34 STRIDE PD 34 LATUDA 34 Rich Cheddar Sauce 34 mesalamine granules 34 peak plasma concentrations 34 locomotor activity 34 rectal temperature 34 WOMAC pain 34 plasma viremia 34 atazanavir ritonavir 34 #days [001] 34 ≤ 34 embassies legations consular 34 ZOMIG Nasal Spray 34 spokeswoman Lucia Pasquini 34 indefinite quantity indefinite 34 periprocedural 34 plasma glucose levels 34 artificially lengthen 34 RLS symptoms 34 oral corticosteroid 34 COPD exacerbation 34 RECIST criteria 34 Postoperatively 34 mortality morbidity 34 label dose titration 34 aortic crossclamp 34 DLTs 34 wildly varying intensities 34 joint contracture 34 indefinite 34 nonoverlapping 34 ipsilateral stroke 34 Hemopurifier ® treatments 34 Hormonal therapy 34 SOUTH Soil moisture 34 gout flare 34 passed uneventfully 34 lymphocyte count 34 severe exacerbations 34 adjunctive placebo 34 placebo controlled trials 34 acute asthma exacerbations 34 CD4 lymphocyte count 34 varying distances 34 Oswestry Disability Index 34 ADAS Cog 34 alotted 34 CDI recurrence 34 dipyridamole plus 34 UPDRS scores 34 central corneal thickness 34 dose proportionality 34 annularity 34 clinically meaningful improvements 34 methotrexate therapy 34 osmolality 34 dose proportional pharmacokinetics 34 Barometric pressure 33 flexion contracture 33 Hb levels 33 emetic episodes 33 extent 33 prepayment speeds 33 bpm beats 33 Entry Period 33 #mg/dl 33 distinct substructures 33 systolic BP 33 prior 33 #.#hrs [003] 33 TSA Registered Traveler 33 echocardiographic parameters 33 femoral shaft fracture 33 lengthier 33 DAS# remission 33 neurologic dysfunction 33 unmeasured confounding 33 Gov't imposes 33 #hour 33 interquartile range IQR 33 rituximab monotherapy 33 peri procedural 33 Rollei dp# 33 cervical secretions 33 hypopneas 33 decadal scale 33 pCR 33 surgical debulking 33 clock opioid 33 Shortened 33 offseason workouts minicamps 33 Maximum 33 neurologic progression 33 predefined threshold 33 ispinesib administered 33 afebrile 33 immobility 33 diapause 33 angiographic restenosis 33 serum magnesium 33 ≥ Grade 33 GLP1 agonist 33 Vectical TM Ointment 33 nonpeak 33 insomnia somnolence 33 emesis 33 oxyhemoglobin 33 neutrophil counts 33 orientational 33 sd = 33 enuresis 33 atherothrombotic 33 Energyintel analyst George Orwel 33 DSCRs 33 carotid IMT 33 pharmacokinetic characteristics 33 cycles 33 mimimum 33 nadroparin 33 extend 33 maximal treadmill 33 plasma glucose 33 linearly proportional 33 Chavez Alo Presidente 33 anagen phase 33 manic hypomanic 33 vary depending 33 blood glucose concentrations 33 inhaled anticholinergics 33 CYT# QbG# 33 glutamate glutamine 33 Free Survival PFS 33 confirmed thrombotic cardiovascular 33 1uA 33 AUC0 #hr 33 transaminase levels 33 hypoglycaemic episodes 33 indefinite quantity contract 33 Auctioneers clerking records 33 rate mortgages FRMs 33 oral analgesics 33 virological response 33 hemoglobin A1c HbA1c 33 CK # plasma 33 tiotropium 33 kyr 33 leucopenia 33 virologic failure 33 biochemical marker 33 pa tient 33 intraclass correlation coefficient 33 parameters 33 symptomatic VTE 33 undervoltage 33 mg kg IV 33 mL kg 33 rectal bleeding subscore 33 twoweek 33 indefinite quantity 33 histrelin 33 glycogen depletion 33 MSIM strives 33 morbidity mortality 33 dose prednisone 33 randomisation 33 Persistent Sleep 33 6hr 33 NIH CPSI 33 Shrinkage 33 Repricing Gap 33 CIMZIA R 33 Major Depressive Disorder MDD 33 sigmoid 33 timescale 33 aminotransferase levels 33 creatine supplementation 33 relapsed MM 33 care hospitals LTACHs 33 serum cotinine 33 prodromal 33 epigastric pain 33 ug kg 33 indefinate 33 H2RAs 33 vigorous aerobic 33 anticoagulant therapy 33 breath wheezing coughing 33 status epilepticus 33 ancrod 33 actigraph 33 EDSS score 33 flowrate 33 inverse ProFunds returns 33 Metastatic colorectal cancer 33 expiratory 33 Preska imposed 33 twoand half 33 knee flexion 33 True thicknesses 33 mg/m2 cohort 33 LHRH agonists 33 menstrual bleeding 33 stays 33 AGILECT R 33 placebo controlled 33 quadrillionths 33 timescales 33 Bone density 33 focal length 33 mianserin 33 Sophisticated treadmills 33 hours 33 tipranavir r 33 ultrashort 33 SOUTHWEST Soil moisture 33 Dr. Chenchen Wang 33 apneas 33 glucose concentrations 33 Severity 33 PFPS 33 venlafaxine ER 33 ± SD 33 presumptively reasonable 33 Cohort Study MACS 33 SBMs 33 Beetle Bailey nears 33 FOSRENOL ® 33 fatty infiltration 33 IFN alpha XL 33 inflammatory biomarkers 33 airflow limitation 33 erosive esophagitis 33 6MWD 33 pulmonary exacerbations 33 oncologic outcomes 33 Treatment emergent adverse 33 presentence custody 33 bullspread 33 inpatient hospitalization 33 #:# randomization 33 postmenopausal estrogen 33 poststroke depression 33 insulin detemir 33 headache dizziness fatigue 33 carboplatin AUC 33 monotonically 33 CDAI score 33 p = #.# [003] 33 Orgasms occur 33 QT QTc 33 Dietary habits 33 Psychosocial interventions 33 LTIFR 33 dual antiplatelet 33 affreightment 33 nicotinamide adenine dinucleotide phosphate 33 gastroduodenal 33 β blocker 33 serodiscordant couples 33 Thorough QT 33 systolic function 33 clonidine hydrochloride 33 nausea dizziness vomiting 33 postop 33 Gafill 33 Cardiorespiratory fitness 33 lifespans 33 S#B [002] 33 uninterrupted 33 serum phosphate 33 urinary N telopeptide 33 NATRECOR R 33 coverage ratios DSCR 33 dyspnea 33 PWM frequency 33 nonoperative treatment 33 syncopal 33 Kumpel barriers 33 acetazolamide 33 flow mediated dilation 33 creatinine clearance CrCl 33 AUC0 33 gout flares 33 autoregulation 33 intermittent 33 onsets 33 lipase units 33 foveal thickness 33 thrombus formation 33 Calorie restriction 33 OFZ curve 33 Date Exercisable 33 muscles atrophied 33 #mg q8h 33 creatine kinase MB 33 HBeAg seroconversion 33 ADAS cog 33 mso font pitch 33 luteal phase 33 GATTEX therapy 33 μg mL 33 intravenous tPA 33 glycemia 33 GnRH antagonist 33 EndoTAGTM 1 33 Younger Dryas cold 33 covariate 33 postoperative hemorrhage 33 P FLOATs 33 conjugated equine estrogen 33 ABILIFY Injection 33 #month 33 prolactin levels 33 custodial remand 33 laterality 33 racemic albuterol 33 Karatz retroactively tied 33 nonobstructive CAD 33 subordinate liens 33 urinary excretion 33 CI# [002] 33 ziprasidone 33 euthymic 33 mcg kg 33 femtoseconds 33 luteal 33 strikelength 33 residual platelet reactivity 33 intravitreal injections 33 pegylated interferon alfa 2b 33 frequent awakenings 33 multi decadal 32 thrombin inhibiting aptamer 32 IOP lowering 32 solar irradiance 32 EEG abnormalities 32 pharmacokinetics PK 32 QAB# indacaterol 32 elbow flexion 32 immuno suppression 32 ug dose 32 antidiabetic medications 32 mammal evolution Demere 32 NUEDEXTA arm 32 impaired endothelial 32 Shyne Mystikal Gucci Mane 32 dial +#-#-#-# [003] 32 mg kg hr 32 body habitus 32 nasal aerosol 32 oral olanzapine 32 antibody titer 32 HBV DNA levels 32 affective psychosis 32 really casually Buhai 32 tele ICU 32 intensity aerobic exercise 32 milliseconds ms 32 bowel resection 32 weekly subcutaneous injections 32 O PPDS 32 PegIFN RBV 32 myocardial ischaemia 32 constipation akathisia postural hypotension 32 normal LLN 32 Intraocular pressure 32 hemodynamically stable 32 Gabapentin GR 32 Peg riba 32 ejaculatory function 32 interplanetary magnetic 32 IRLS score 32 subcutaneous SC 32 polysomnogram 32 oneweek 32 gestation periods 32 divisibility 32 DES implantation 32 CREL CDO 32 rotigotine 32 bezafibrate 32 Because mutated kinases 32 recognized ratably 32 expenditure framework MTEF 32 anogenital distance 32 mg subcutaneously 32 Active Ulcerative Colitis 32 incidence ≥ 32 prespecified 32 maximal aerobic capacity 32 extending 32 Calcium intake 32 to# [001] 32 Insulin PH# 32 DAS# CRP 32 PSVT 32 DHCA 32 Lucentis ranibizumab Genentech 32 vigorous exertion 32 Ceplene/IL-2 32 dephasing 32 encompassed 32 μg liter 32 ABC/3TC 32 evaluable subjects 32 Zemplar Capsules 32 Symptom severity 32 neurologic deficits 32 metocean 32 mIU ml 32 fluticasone salmeterol 32 NATRECOR ® 32 plasma glucose concentration 32 Furnished apartments 32 serum urate 32 CDAI 32 comorbid disorders 32 Venous thromboembolism 32 treatment naive genotype 32 #hrs [002] 32 Perceiva 32 primary efficacy endpoint 32 5 HT2C receptor 32 swelling stiffness 32 PM#.# concentrations 32 Exercises biofeedback 32 ischemic lesions 32 intravenous CK # 32 amenorrhea 32 Qmax 32 unduplicated headcount 32 acute febrile 32 endoscopic remission 32 GENASIS clinical 32 adenoid tissue 32 UNMIT mandate 32 Nocturia 32 Darlene Chiu spokeswoman 32 Soyuz undocking 32 allowable 32 arterial oxygen saturation 32 elevated IOP 32 El Niño Southern Oscillation 32 Adverse effects 32 expiry 32 equivalents FTEs 32 unresectable HCC 32 plasminogen activators 32 SCr 32 Zen meditators 32 eprodisate Fibrillex TM 32 LUNESTA 32 pharmacodynamics PD 32 Mileage reimbursement 32 Asentar 32 JLENS 32 photoperiodic 32 Villeta U sand 32 Hybrid ARMs 32 diurnal 32 wore pedometers 32 Observational studies 32 LIBOR resets 32 fatal arrhythmic 32 akinesia 32 MS CDMS 32 service MADS coverage 32 recurrent genital herpes 32 pulmonary dysfunction 32 hypomanic episode 32 androgen ablation 32 CIMZIA ™ 32 carboplatin AUC 6 32 DISC1 protein 32 Prolonged 32 Dextofisopam Phase 2b 32 colorectal adenoma 32 L PPDS 32 androgen ablation therapy 32 uric acid lowering 32 reactogenicity 32 maxi mum 32 polysomnographic 32 thromboprophylaxis 32 offhire 32 micturition 32 Fig. 2D 32 poststroke 32 psychomotor speed 32 oral FTY# 32 guanfacine 32 Liquidity Adjustment Facility 32 potassium supplementation 32 chest radiography 32 Diamyd ® 32 HbA 1c levels 32 orthostatic 32 APEX AMI 32 RNA copies mL 32 pathologic fractures 32 EMBEDA ™ 32 amyloidogenic